Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Two-year real-world retrospective safety evaluation with onabotulinumtoxinA across multiple therapeutic indications: Findings from the SYNCHRONIZE study.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: March 28, 2025
SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication.
Journal: Toxins
Published: August 29, 2024
Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 24, 2020
Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: January 26, 2018
Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic review.
Journal: Neurology. Clinical practice
Published: June 01, 2017
A Topical Adhesive Containing Anesthetic and Heating Components to Reduce Injection Pain with Subcutaneous Multiple Sclerosis Medications: A Pilot Study.
Journal: International journal of MS care
Published: March 01, 2017
A Randomized Crossover Trial of Dalfampridine Extended Release for Effect on Ambulatory Activity in People with Multiple Sclerosis.
Journal: International journal of MS care
Published: August 24, 2016
A randomized placebo-controlled trial of duloxetine for central pain in multiple sclerosis.
Journal: International journal of MS care
Published: April 21, 2015
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
Journal: International journal of MS care
Published: October 23, 2014
Last Updated: 09/26/2026